0,967  0,002  Antioxidant
0,842  0,004  Caspase 3 stimulant
0,805  0,015  Antiinflammatory
0,788  0,004  Antineoplastic (brain cancer)
0,776  0,019  Apoptosis agonist
0,756  0,012  Antineoplastic (lung cancer)
0,743  0,015  Antineoplastic (breast cancer)
0,716  0,005  NOS2 expression inhibitor
0,716  0,006  5 Hydroxytryptamine release stimulant
0,714  0,009  Antihypercholesterolemic
0,697  0,004  Hepatoprotectant
0,686  0,005  Cardioprotectant
0,693  0,015  Antineoplastic (colorectal cancer)
0,684  0,006  Nitric oxide antagonist
0,685  0,022  Transcription factor NF kappa B inhibitor
0,666  0,005  Antineoplastic (glioma)
0,657  0,007  Hepatic disorders treatment
0,658  0,011  Chemopreventive
0,648  0,016  Alzheimer's disease treatment
0,649  0,018  Antineoplastic (colon cancer)
0,621  0,004  ICAM1 expression inhibitor
0,616  0,008  Apoptosis antagonist
0,600  0,008  Free radical scavenger
0,614  0,034  Caspase 9 stimulant
0,570  0,005  Topoisomerase II inhibitor
0,569  0,010  Antiprotozoal (Leishmania)
0,582  0,026  Antileukemic
0,562  0,010  Hypoglycemic
0,554  0,037  Antidiabetic
0,554  0,037  Cyclophilin D inhibitor
0,525  0,010  Vascular (periferal) disease treatment
0,532  0,023  Antineoplastic (ovarian cancer)
0,512  0,011  Antimitotic
0,518  0,029  Prostate cancer treatment
0,499  0,024  CYP2C19 inhibitor
0,470  0,016  CYP3A4 inhibitor
0,458  0,011  Antineoplastic (small cell lung cancer)
0,449  0,009  Genotoxic
0,465  0,028  Antineoplastic (melanoma)
0,454  0,020  Antineoplastic (glioblastoma multiforme)
0,437  0,007  VCAM1 expression inhibitor
0,447  0,019  Antineoplastic (lymphoma)
0,437  0,018  Vasodilator
0,440  0,030  Antineoplastic (cervical cancer)
0,408  0,005  Neurotrophic factor enhancer
0,408  0,005  Topoisomerase I inhibitor
0,405  0,006  Diabetic nephropathy treatment
0,407  0,011  Antineoplastic (squamous cell carcinoma)
0,415  0,020  Antihypertriglyceridemic
0,401  0,012  Melanin inhibitor
0,411  0,022  Antineoplastic (renal cancer)
0,412  0,025  Antipyretic
0,404  0,030  Mutagenic
0,396  0,022  Angiogenesis stimulant
0,390  0,031  Proliferative diseases treatment
0,352  0,005  Nitric-oxide synthase stimulant
0,417  0,072  TNF expression inhibitor
0,362  0,023  Cyclic AMP phosphodiesterase inhibitor
0,369  0,035  Antiamyloidogenic
0,389  0,060  Stroke treatment
0,362  0,037  DNA damaging
0,398  0,078  Antibacterial
0,317  0,006  Topoisomerase II alpha inhibitor
0,350  0,043  Cytotoxic
0,307  0,005  Estrogen agonist
0,379  0,078  Antiprotozoal
0,306  0,004  Histone deacetylase SIRT1 stimulant
0,306  0,004  Histone deacetylase stimulant
0,334  0,040  Antidiabetic symptomatic
0,326  0,041  Antineoplastic (liver cancer)
0,295  0,014  Acetylcholinesterase inhibitor
0,303  0,021  Antineoplastic (carcinoma)
0,329  0,048  Sensitization
0,291  0,011  Carcinogenic, group 1
0,282  0,004  Carcinogenic, group 2A
0,297  0,020  Skin whitener
0,297  0,021  Acaricide
0,335  0,060  Antiischemic
0,289  0,019  NOS3 expression enhancer
0,328  0,062  NOS3 expression inhibitor
0,285  0,020  Amylase inhibitor
0,273  0,010  Antihemorrhagic
0,274  0,016  Antidiarrheal
0,324  0,070  Vasodilator, coronary
0,297  0,046  Amyloid beta aggregation inhibitor
0,273  0,023  Lipid peroxidase inhibitor
0,273  0,023  Cholinergic
0,343  0,103  Histamine release inhibitor
0,333  0,096  Immunosuppressant
0,283  0,049  Antineoplastic (sarcoma)
0,292  0,060  Antineoplastic (non-small cell lung cancer)
0,292  0,065  Antihypoxic
0,295  0,069  Antiosteoporotic
0,293  0,071  Antineoplastic (pancreatic cancer)
0,277  0,058  Cytostatic
0,294  0,075  Antineoplastic (osteosarcoma)
0,299  0,083  AR expression inhibitor
0,270  0,056  Antineoplastic (lymphocytic leukemia)
0,345  0,138  Alpha-glucosidase inhibitor
0,247  0,042  P-glycoprotein inhibitor
0,303  0,099  CYP3A4 substrate
0,270  0,073  GST M1-1 substrate
0,203  0,007  CDC-like kinase 3 inhibitor
0,223  0,027  Antineoplastic (bone cancer)
0,317  0,129  Antiparkinsonian
0,210  0,023  DNA intercalator
0,275  0,093  Antifungal
0,267  0,086  Antineoplastic (multiple myeloma)
0,277  0,098  Bone diseases treatment
0,180  0,016  Beta glucuronidase inhibitor
0,198  0,037  Tubulin antagonist
0,184  0,025  Cyclooxygenase 3 inhibitor
0,162  0,006  Estrogen receptor beta agonist
0,194  0,039  CDC-like kinase 1 inhibitor
0,207  0,052  Muscle relaxant
0,195  0,042  Skeletal muscle relaxant
0,300  0,152  Antiarthritic
0,217  0,076  Antiparasitic
0,149  0,010  Phosphodiesterase 6D inhibitor
0,224  0,090  Tumour necrosis factor alpha release inhibitor
0,165  0,031  Microtubule formation inhibitor
0,142  0,009  ATPase (Vacuolar H+) inhibitor
0,240  0,111  Antidepressant
0,157  0,029  Alpha 2c adrenoreceptor antagonist
0,200  0,074  Pneumotoxic
0,178  0,060  ATPase inhibitor
0,144  0,026  Estrogen antagonist
0,135  0,019  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,161  0,045  Antifungal (Cryptococcus)
0,150  0,034  Antineoplastic (uterine cancer)
0,153  0,038  Beta amyloid protein antagonist
0,191  0,078  Abortion inducer
0,131  0,018  Restless leg syndrome treatment
0,161  0,051  Antifungal enhancer
0,140  0,033  Antineoplastic antibiotic
0,227  0,120  CYP1A2 substrate
0,223  0,116  Respiratory analeptic
0,189  0,083  5 Hydroxytryptamine 3E antagonist
0,127  0,021  Ornithine decarboxylase inhibitor
0,261  0,156  15-Lipoxygenase inhibitor
0,126  0,026  Estrogen receptor beta antagonist
0,104  0,006  Alpha-mannosidase inhibitor
0,145  0,049  Alkylator
0,140  0,044  Papain-like protease (SARS coronavirus) inhibitor
0,106  0,012  Antitreponemal
0,138  0,044  Carcinogenic, group 2B
0,177  0,083  Antihelmintic
0,233  0,141  Antithrombotic
0,225  0,133  Mood disorders treatment
0,208  0,117  Lipoprotein disorders treatment
0,182  0,091  Psychostimulant
0,160  0,071  Antiviral (Herpes)
0,135  0,048  DNA repair enzyme inhibitor
0,092  0,005  Endothelin receptor antagonist
0,146  0,059  Cyclooxygenase 1 inhibitor
0,098  0,012  Glutamate (mGluR7) antagonist
0,100  0,017  Postmenopausal disorders treatment
0,132  0,050  Cystathionine beta-synthase inhibitor
0,209  0,129  Analeptic
0,207  0,127  Antidiabetic (type 2)
0,167  0,088  Carcinogenic
0,110  0,031  Transcription factor NF kappa B stimulant
0,086  0,008  Mannosidase inhibitor
0,129  0,052  Alcohol dehydrogenase substrate
0,114  0,037  Acetylcholine M3 receptor agonist
0,183  0,107  Hypolipemic
0,079  0,004  Sodium/glucose cotransporter 2 inhibitor
0,232  0,157  Antiprotozoal (Plasmodium)
0,075  0,005  Endothelin B receptor antagonist
0,084  0,015  Antibiotic Glycopeptide-like
0,128  0,059  Antitussive
0,125  0,058  Monophenol monooxygenase inhibitor
0,078  0,012  Estrogen receptor alpha agonist
0,151  0,086  Prostatic (benign) hyperplasia treatment
0,106  0,044  Alpha 2 adrenoreceptor antagonist
0,274  0,213  Antineoplastic (solid tumors)
0,122  0,062  Protein-tyrosine phosphatase 1B inhibitor
0,149  0,091  Interleukin 6 antagonist
0,121  0,064  Antiviral (Influenza B)
0,124  0,067  Antiviral (Hepatitis B)
0,062  0,005  Endothelin A receptor antagonist
0,162  0,105  UGT1A1 substrate
0,102  0,046  Antineoplastic alkaloid
0,090  0,037  T cell inhibitor
0,069  0,017  Topoisomerase II beta inhibitor
0,196  0,145  Lipoxygenase inhibitor
0,072  0,023  Alpha tubulin antagonist
0,152  0,104  Platelet adhesion inhibitor
0,084  0,036  Phosphodiesterase VI inhibitor
0,052  0,005  Sodium/glucose cotransporter inhibitor
0,082  0,036  Selectin antagonist
0,088  0,045  Glycine receptor antagonist
0,178  0,138  Spasmolytic
0,128  0,090  Cyclooxygenase inhibitor
0,050  0,013  Antibiotic Aminoglycoside-like
0,149  0,113  LDLR expression enhancer
0,085  0,049  Phosphodiesterase 11A inhibitor
0,085  0,049  Phosphodiesterase XI inhibitor
0,092  0,056  Actinic keratosis treatment
0,082  0,048  Na+ K+ transporting ATPase inhibitor
0,201  0,169  Antihypertensive
0,149  0,120  Phobic disorders treatment
0,129  0,102  Protein-tyrosine phosphatase inhibitor
0,075  0,049  Lipase inhibitor
0,180  0,154  CYP1A2 inhibitor
0,040  0,015  Melatonin 1 agonist
0,100  0,077  DOPA decarboxylase inhibitor
0,165  0,142  Immunostimulant
0,063  0,040  Neuraminidase inhibitor
0,050  0,028  Microtubule stabilization
0,052  0,030  Factor III inhibitor
0,081  0,060  Antiprotozoal activity enhancer
0,133  0,113  Prostate disorders treatment
0,062  0,044  Nitric oxide donor
0,029  0,012  Sodium/glucose cotransporter 1 inhibitor
0,039  0,023  Kinesin antagonist
0,039  0,023  Kinesin-like protein 1 inhibitor
0,046  0,035  Phosphodiesterase 6C inhibitor
0,069  0,059  Alpha 2a adrenoreceptor antagonist
0,111  0,103  Protein kinase stimulant
0,072  0,063  Macrophage migration inhibitory factor inhibitor
0,106  0,097  Cyclooxygenase 2 inhibitor
0,129  0,123  Ca2+-transporting ATPase inhibitor
0,134  0,130  UDP-glucuronosyltransferase substrate
0,109  0,109  UGT2B15 substrate

